~~<i id='894A0E3436'><strike id='894A0E3436'><tt id='894A0E3436'><pre id='894A0E3436'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

author：explore 2025-10-06 14:11:01 Page View：69

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： WHO recommends dropping component of many flu vaccines
Next article： Cancer drug shortages should be causing more outrage

leisure time

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

Biden praises World Series champion Astros for impact off the field during White House celebration

0:38PresidentJoeBidenholdsupajerseyasteammanageroftheHoustonAstrosDustyBakerlooksonduringanEastRoome

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

1:13AcheesesteakandfrenchfriestoppedwithMalibuBarbieDreamDrizzle.Gino'sCheeseSteakandOnionBarbiemayn